CEACAM5 and neoplasm: Paganelli et al. reported streptavidin as a linker to link the biotinylated αCEA antibody and biotinylated radioactive 111In tracker to increase the tumor accumulation of 111In-αCEA antibody in CEA-positive patients, but 63% of patients had the anti-streptavidin antibody [27].